+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Rx/Reimbursement Adult Incontinence in Latvia

  • ID: 4517595
  • Report
  • Region: Latvia
  • 13 pages
  • Euromonitor International
1 of 2
Adult incontinence products are reimbursed in Latvia for a set list of diagnosed conditions. Patients diagnosed with these conditions are eligible to a 50% reimbursement from the state for up to three units of adult incontinence. The state support mechanism is implemented as a subsidy to drugstores for prescriptions turned in by patients. Thus, patients need a prescription from a doctor to receive the reimbursement.

The Rx/Reimbursement adult incontinence in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2023 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 2
Rx/reimbursement Adult Incontinence in Latvia

List of Contents and Tables
Headlines
Prospects
Untapped Market Potential
Reimbursement System Seen To Be Insufficient
High Barriers and Low Competition
Category Data
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2013-2018
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2013-2018
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2018-2023
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2018-2023
Executive Summary
Strong Economic Performance Fuels Growth
Comfort and Convenience Key To New Product Development
International Brands Lead But Private Label Provides Stiff Competition
Distribution Continues To Be Dominated by Three Channels
Cautious Optimism Regarding the Future of Tissue and Hygiene in Latvia
Market Indicators
Table 5 Birth Rates 2013-2018
Table 6 Infant Population 2013-2018
Table 7 Female Population by Age 2013-2018
Table 8 Total Population by Age 2013-2018
Table 9 Households 2013-2018
Table 10 Forecast Infant Population 2018-2023
Table 11 Forecast Female Population by Age 2018-2023
Table 12 Forecast Total Population by Age 2018-2023
Table 13 Forecast Households 2018-2023
Market Data
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2013-2018
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2013-2018
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2014-2018
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2015-2018
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2013-2018
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2013-2018
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2018
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2018-2023
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2018-2023
Sources
Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll